Literature DB >> 31515727

The Short-Term Effects of Roux-en-Y Gastric Bypass on Renal Excretion of Sodium and Its Association with Blood Pressure.

Josue Emiliano López-Martínez1, Adolfo Chávez-Negrete2, Arturo Abraham Rodríguez-González3, Mario Antonio Molina-Ayala4, Silvia Villanueva-Recillas5, Pablo Maravilla6, Aida Monserrat Reséndiz-Barragán7, Enrique Rentería-Palomo8, Martín Edgardo Rojano-Rodríguez9.   

Abstract

INTRODUCTION: Bariatric surgery has been shown to be effective in reducing weight and has benefits, such as lowering blood pressure. An increase in urinary sodium excretion has been suggested as a possible mechanism. This study explored changes in sodium excretion and their correlation with blood pressure after Roux-en-Y gastric bypass.
MATERIALS AND METHODS: This study was conducted on 28 obese participants with body mass index (BMI) of 44.54 ± 7.81 kg/m2 who underwent gastric bypass. Before surgery and at the third and sixth months after gastric bypass, blood pressure, urinary sodium concentration, 24-hour (24-h) urinary sodium excretion, and fractional excretion of sodium were evaluated. In addition, serum sodium and potassium levels were determined. Nonparametric tests were used to analyze the data.
RESULTS: Blood pressure decreased after surgery and remained at low levels over the 3- and 6-month periods. The urinary sodium concentration increased at 3 months after surgery; however, the 24-h urinary sodium excretion and urine volume decreased. Interestingly, although some associations between variables were observed, significant correlations between the 24-h urinary sodium excretion and the systolic, diastolic, and mean blood pressures were found. In addition, the urine volume was higher in the sixth month than in the third month following surgery.
CONCLUSIONS: In the months immediately following surgery, a low-salt and low-volume diet favors decreases in urine volume and 24-h urinary sodium excretion. In addition, in the sixth month after surgery, an association between blood pressure and 24-h urinary sodium excretion was observed.

Entities:  

Keywords:  Bariatric surgery; Blood pressure; Roux-en-Y gastric bypass; Severe obesity; Urinary sodium concentration

Year:  2020        PMID: 31515727     DOI: 10.1007/s11695-019-04134-6

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  24 in total

1.  The INTERSALT study: background, methods and main results. INTERSALT Co-operative Research Group.

Authors:  G Rose; J Stamler
Journal:  J Hum Hypertens       Date:  1989-10       Impact factor: 3.012

Review 2.  New guidelines for potassium replacement in clinical practice: a contemporary review by the National Council on Potassium in Clinical Practice.

Authors:  J N Cohn; P R Kowey; P K Whelton; L M Prisant
Journal:  Arch Intern Med       Date:  2000-09-11

3.  [Laparoscopic Roux-en-Y gastric bypass surgery for morbid obesity. Experience at the Nacional de Ciencias Médicas y Nutrición Salvador Zubirán].

Authors:  María Elena Romero-Lbargüengoitia; Israel Lerman-Garber; Miguel Francisco Herrera-Hernández; Juan Pablo-Pantoja; Mauricio Sierra-Salazar; Federico López-Rosales; Margarita Zamora-Barrón; Angeles Vargas-Martínez; Eduardo García-García
Journal:  Rev Invest Clin       Date:  2009 May-Jun       Impact factor: 1.451

4.  Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss.

Authors:  Harvey J Sugerman; Luke G Wolfe; Domenic A Sica; John N Clore
Journal:  Ann Surg       Date:  2003-06       Impact factor: 12.969

5.  Salt intakes around the world: implications for public health.

Authors:  Ian J Brown; Ioanna Tzoulaki; Vanessa Candeias; Paul Elliott
Journal:  Int J Epidemiol       Date:  2009-04-07       Impact factor: 7.196

Review 6.  INTERMAP: background, aims, design, methods, and descriptive statistics (nondietary).

Authors:  J Stamler; P Elliott; B Dennis; A R Dyer; H Kesteloot; K Liu; H Ueshima; B F Zhou
Journal:  J Hum Hypertens       Date:  2003-09       Impact factor: 3.012

7.  [Prevalence of obesity in Mexican adults 2000-2012].

Authors:  Simón Barquera; Ismael Campos-Nonato; Lucía Hernández-Barrera; Adolfo Pedroza; Juan A Rivera-Dommarco
Journal:  Salud Publica Mex       Date:  2013

Review 8.  New perspectives on the origin of hypertension; the role of the hypothalamic melanocortin system.

Authors:  Anne-Maj Samuelsson
Journal:  Exp Physiol       Date:  2014-09       Impact factor: 2.969

Review 9.  Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis.

Authors:  Katherine M Flegal; Brian K Kit; Heather Orpana; Barry I Graubard
Journal:  JAMA       Date:  2013-01-02       Impact factor: 56.272

Review 10.  Beyond obesity and lifestyle: a review of 21st century chronic disease determinants.

Authors:  Garry Egger; John Dixon
Journal:  Biomed Res Int       Date:  2014-04-07       Impact factor: 3.411

View more
  4 in total

Review 1.  The Impact of Bariatric Surgery Versus Non-Surgical Treatment on Blood Pressure: Systematic Review and Meta-Analysis.

Authors:  Laicheng Wang; Meihua Lin; Jianjian Yu; Zongcheng Fan; Shunpeng Zhang; Yunchai Lin; Xin Chen; Feng Peng
Journal:  Obes Surg       Date:  2021-09-14       Impact factor: 3.479

Review 2.  Changes in Antihypertensive Medication Following Bariatric Surgery.

Authors:  Gabriel S Tajeu; Emily Johnson; Mason Buccilla; Crystal A Gadegbeku; Shane Janick; Daniel Rubin; Rohit Soans; Vikram J Eddy; David B Sarwer
Journal:  Obes Surg       Date:  2022-01-26       Impact factor: 3.479

3.  Characteristics and resolution of hypertension in obese African American bariatric cohort.

Authors:  Charu Gandotra; Motahar Basam; Ankit Mahajan; Julius Ngwa; Gezzer Ortega; Daniel Tran; Terrence M Fullum; Zaki A Sherif
Journal:  Sci Rep       Date:  2021-01-18       Impact factor: 4.379

Review 4.  Effect of Bariatric Surgery on Flow-Mediated Vasodilation as a Measure of Endothelial Function: A Systematic Review and Meta-Analysis.

Authors:  Tannaz Jamialahmadi; Mona Alidadi; Stephen L Atkin; Matthew Kroh; Wael Almahmeed; Seyed Adel Moallem; Khalid Al-Rasadi; John H Rodriguez; Raul D Santos; Massimiliano Ruscica; Amirhossein Sahebkar
Journal:  J Clin Med       Date:  2022-07-13       Impact factor: 4.964

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.